Australian researchers develop a novel lipid nanoparticle that delivers mRNA into HIV-hiding white blood cells, potentially enabling the virus's elimination.
Circle's landmark $1.1B NYSE IPO debut highlights growing investor enthusiasm for digital assets and the company's regulatory compliance as a model for future crypto IPOs.
Guatemalan man returned to US after court orders, highlighting ongoing judicial oversight of immigration enforcement practices.
Australian researchers develop a novel lipid nanoparticle that delivers mRNA into HIV-hiding white blood cells, potentially enabling the virus's elimination.
Circle's landmark $1.1B NYSE IPO debut highlights growing investor enthusiasm for digital assets and the company's regulatory compliance as a model for future crypto IPOs.
Guatemalan man returned to US after court orders, highlighting ongoing judicial oversight of immigration enforcement practices.